» Articles » PMID: 16754968

An Improved Resolution Structure of the Human Beta Common Receptor Involved in IL-3, IL-5 and GM-CSF Signalling Which Gives Better Definition of the High-affinity Binding Epitope

Overview
Date 2006 Jun 7
PMID 16754968
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

X-ray diffraction has been used to produce and refine a model of the extracellular domains of the beta common cytokine receptor. A minor improvement in resolution has resulted in improved electron-density maps, which have given a clearer indication of the position and stabilization of the key residues Tyr15, Phe79, Tyr347, His349, Ile350 and Tyr403 in the elbow region between domain 1 and domain 4 of the dimer-related molecule.

Citing Articles

The JAK-STAT pathway: from structural biology to cytokine engineering.

Lv Y, Qi J, Babon J, Cao L, Fan G, Lang J Signal Transduct Target Ther. 2024; 9(1):221.

PMID: 39169031 PMC: 11339341. DOI: 10.1038/s41392-024-01934-w.


Structure of the interleukin-5 receptor complex exemplifies the organizing principle of common beta cytokine signaling.

Caveney N, Rodriguez G, Pollmann C, Meyer T, Borowska M, Wilson S Mol Cell. 2024; 84(10):1995-2005.e7.

PMID: 38614096 PMC: 11102305. DOI: 10.1016/j.molcel.2024.03.023.


EPO does not promote interaction between the erythropoietin and beta-common receptors.

Cheung Tung Shing K, Broughton S, Nero T, Gillinder K, Ilsley M, Ramshaw H Sci Rep. 2018; 8(1):12457.

PMID: 30127368 PMC: 6102255. DOI: 10.1038/s41598-018-29865-x.


The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.

Dhagat U, Hercus T, Broughton S, Nero T, Cheung Tung Shing K, Barry E MAbs. 2018; 10(7):1018-1029.

PMID: 29969365 PMC: 6204844. DOI: 10.1080/19420862.2018.1494107.


Computational design and experimental characterization of a novel β-common receptor inhibitory peptide.

Kilar C, Sekharan S, Sautina L, Diao Y, Keinan S, Shen Y Peptides. 2018; 104:1-6.

PMID: 29635062 PMC: 6475910. DOI: 10.1016/j.peptides.2018.04.001.


References
1.
McQualter J, Darwiche R, Ewing C, Onuki M, Kay T, Hamilton J . Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 2001; 194(7):873-82. PMC: 2193476. DOI: 10.1084/jem.194.7.873. View

2.
Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

3.
Cook A, Braine E, Campbell I, Rich M, Hamilton J . Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001; 3(5):293-8. PMC: 64841. DOI: 10.1186/ar318. View

4.
Winn M, Isupov M, Murshudov G . Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr. 2001; 57(Pt 1):122-33. DOI: 10.1107/s0907444900014736. View

5.
Carr P, Gustin S, Church A, Murphy J, Ford S, Mann D . Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration. Cell. 2001; 104(2):291-300. DOI: 10.1016/s0092-8674(01)00213-6. View